Literature DB >> 15483039

Long-term bisphosphonate treatment of bone metastases from renal cell carcinoma.

M Dror Michaelson, Daniel I Rosenthal, Matthew R Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15483039     DOI： 10.1200/JCO.2004.99.142

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Angiosarcoma involving colon and bone successfully responded to paclitaxel and zoledronate: case report.

Authors:  Kenji Matsuda; Katsunari Takifuji; Tsukasa Hotta; Shozo Yokoyama; Junji Ieda; Kenji Arii; Masao Ichinose; Yasushi Nakamura; Hironao Yasuoka; Hiroki Yamaue
Journal:  Clin J Gastroenterol       Date:  2012-12-25

2.  A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo.

Authors:  K Sato; T Yuasa; M Nogawa; S Kimura; H Segawa; A Yokota; T Maekawa
Journal:  Br J Cancer       Date:  2006-10-17       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.